Winton Matthew
SEC insider (Form 3/4/5 filer). CIK 0001971400. Chief Commercial and Business at CervoMed Inc. (CRVO) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in BOSTON, MA.
Companies Winton Matthew has filed insider reports for
- CervoMed Inc. (CRVO): Officer, Chief Commercial and Business
- Inozyme Pharma, Inc. (INZY): Officer, COO
Winton Matthew
CIK: 0001971400
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Oct 22, 2026CRVO
CervoMed Inc.
AwardDirectStock Option (Right to Buy)
19.1K shares- - Feb 11, 2026CRVO
CervoMed Inc.
AwardDirectStock Option (Right to Buy)
30K shares- - Nov 18, 2025CRVO
CervoMed Inc.
PurchaseDirect1.5K shares at avg. $7.95$12K - Nov 17, 2025CRVO
CervoMed Inc.
PurchaseDirect3.5K shares at avg. $8.43$30K - Nov 14, 2025CRVO
CervoMed Inc.
PurchaseDirect10K shares at avg. $7.57$76K - Oct 6, 2025CRVO
CervoMed Inc.
AwardDirectStock Option (Right to Buy)
75K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Tender OfferDirect21.7K shares at avg. $4.00$87K - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectRestricted Stock Units
41.5K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
145K shares- - Jun 25, 2025INZY
Inozyme Pharma, Inc.
AwardDirect14.4K shares at avg. $0.74$11K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  CRVO CervoMed Inc. | Award Stock Option (Right to Buy) | 19,100 | - | - | Direct |
| Feb 11, 2026 | CRVO CervoMed Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Nov 18, 2025 | CRVO CervoMed Inc. | Purchase | 1,500 | $7.95 | $11,925 | Direct |
| Nov 17, 2025 | CRVO CervoMed Inc. | Purchase | 3,500 | $8.43 | $29,505 | Direct |
| Nov 14, 2025 | CRVO CervoMed Inc. | Purchase | 10,000 | $7.57 | $75,700 | Direct |
| Oct 6, 2025 | CRVO CervoMed Inc. | Award Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Jul 1, 2025 |  INZY Inozyme Pharma, Inc. | Tender Offer | 21,743 | $4.00 | $86,972 | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Restricted Stock Units | 41,500 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 145,000 | - | - | Direct |
| Jun 25, 2025 | INZY Inozyme Pharma, Inc. | Award | 14,355 | $0.74 | $10,623 | Direct |
1-10 of 14 transactions